Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
BPC-157 has a unique mechanism of action in the body
Hanaoka T et al
E.CaoJ.SluzasE.DelclosK
Tirzepatide operates through dual GLP-1 and GIP receptor agonism , a mechanism that already outperforms standalone GLP-1 drugs like semaglutide in head-to-head trials
1 Orforglipron availabililty Orforglipron clinical trials As of early 2024, Orforglipron is in Phase 3 clinical trials for both obesity and type 2 diabetes 2
US$ 25.60
US$ 29.29
US$ 23.73
US$ 29.04
US$ 29.52
